Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-16

Clinical Trial Update: Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical Study

View source ↗

Summary

A clinical trial update on using Jiangzhuo Qinggan Prescription with Irbesartan to treat essential hypertension with metabolic syndrome, with the trial status n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)
  • Jiangzhuo Qinggan Prescription

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Hypertension, Metabolic Syndrome | Status: UNKNOWN